Published in Eur J Echocardiogr on March 01, 2009
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging (2014) 1.47
Assessment of tissue perfusion by contrast-enhanced ultrasound. Eur Radiol (2010) 1.07
Diagnosis and management of hypertrophic cardiomyopathy. Echo Res Pract (2015) 1.07
Impact of diabetes on postinfarction heart failure and left ventricular remodeling. Curr Heart Fail Rep (2011) 0.96
Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.87
Mobile left ventricular thrombus in left ventricular dysfunction: case report and review of literature. Clin Res Cardiol (2013) 0.84
Current cardiac imaging techniques for detection of left ventricular mass. Cardiovasc Ultrasound (2010) 0.82
Echocardiography: frontier imaging in cardiology. Br J Radiol (2011) 0.81
Contrast-enhanced ultrasound: clinical applications in patients with atherosclerosis. Int J Cardiovasc Imaging (2015) 0.81
Sources of variation and bias in assessing left ventricular volumes and dyssynchrony using three-dimensional echocardiography. Int J Cardiovasc Imaging (2011) 0.81
Principles of transthoracic echocardiographic evaluation. Nat Rev Cardiol (2015) 0.80
Echocardiography in the era of multimodality cardiovascular imaging. Biomed Res Int (2013) 0.79
The NICE guidelines on the assessment of chest pain. J R Soc Med (2012) 0.78
Reliability, repeatability, and reproducibility of pulmonary transit time assessment by contrast enhanced echocardiography. Cardiovasc Ultrasound (2016) 0.78
Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: a summary of evidence-based analyses. Ont Health Technol Assess Ser (2010) 0.78
Noninvasive cardiac imaging in suspected acute coronary syndrome. Nat Rev Cardiol (2016) 0.77
Transthoracic measurement of left coronary artery flow reserve improves the diagnostic value of routine dipyridamole-atropine stress echocardiogram. Arch Med Sci (2013) 0.77
Contrast stress echocardiography in hypertensive heart disease. Cardiovasc Ultrasound (2011) 0.77
Imaging of early modification in cardiomyopathy: the doxorubicin-induced model. Int J Cardiovasc Imaging (2013) 0.77
The Clinical Impact of Bedside Contrast Echocardiography in Intensive Care Settings: A Korean Multicenter Study. Korean Circ J (2015) 0.76
Role of Cardiovascular Ultrasound in the Evaluation of Obese Subjects. J Cardiovasc Echogr (2017) 0.75
Assessment of myocardial perfusion using contrast echocardiography - Case report. J Med Life (2015) 0.75
The potential clinical value of contrast-enhanced echocardiography beyond current recommendations. Cardiovasc Ultrasound (2016) 0.75
Bedside myocardial perfusion assessment with contrast echocardiography. Crit Care (2016) 0.75
Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.75
The Evolving Role and Use of Echocardiography in the Evaluation of Cardiac Source of Embolism. J Cardiovasc Echogr (2017) 0.75
Clinical application and laboratory protocols for performing contrast echocardiography. Indian Heart J (2013) 0.75
Global Coronary Artery Plaque Area is Associated with Myocardial Hypoperfusion in Women with Non-ST Elevation Myocardial Infarction. J Womens Health (Larchmt) (2015) 0.75
Impact of Contrast Echocardiography on Assessment of Ventricular Function and Clinical Diagnosis in Routine Clinical Echocardiography: Korean Multicenter Study. J Cardiovasc Ultrasound (2017) 0.75
The dilemma of ischemia testing with different methods. Echo Res Pract (2014) 0.75
Use of contrast agents with echocardiography in patients with suboptimal echocardiography: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.75
A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS. Future Cardiol (2016) 0.75
Abnormal Myocardial Blood Flow Reserve Observed in Cardiac Amyloidosis. J Cardiovasc Ultrasound (2016) 0.75
Contrast echocardiography in daily clinical practice. Herz (2017) 0.75
Stress Echocardiography in Stable Coronary Artery Disease. Curr Cardiol Rep (2017) 0.75
Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity. Curr Oncol Rep (2017) 0.75
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 7.11
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol (2009) 5.35
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol (2013) 5.11
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J (2004) 2.68
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med (2005) 2.49
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr (2008) 2.25
Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol (2009) 2.24
Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J (2008) 2.22
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr (2008) 2.19
Cardiac resynchronization therapy: Part 1--issues before device implantation. J Am Coll Cardiol (2005) 2.06
EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J (2011) 2.04
Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr (2010) 2.01
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. J Am Coll Cardiol (2005) 1.98
The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr (2007) 1.95
Usefulness of a new miniaturized echocardiographic system in outpatient cardiology consultations as an extension of physical examination. J Am Soc Echocardiogr (2010) 1.92
Therapeutic decision-making for sleep apnea and hypopnea syndrome using home respiratory polygraphy: a large multicentric study. Am J Respir Crit Care Med (2011) 1.84
Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J (2004) 1.82
European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr (2008) 1.77
Left ventricular non-compaction: genetic heterogeneity, diagnosis and clinical course. Int J Cardiol (2009) 1.74
Impact of thrombectomy with EXPort Catheter in Infarct-Related Artery during Primary Percutaneous Coronary Intervention (EXPIRA Trial) on cardiac death. Am J Cardiol (2010) 1.72
Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance. JACC Cardiovasc Imaging (2010) 1.71
Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr (2010) 1.69
Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol (2004) 1.68
Unicuspid aortic valve in adults: a systematic review. J Heart Valve Dis (2010) 1.68
Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methods. J Am Coll Cardiol (2005) 1.67
Pocket-size hand-held cardiac ultrasound as an adjunct to clinical examination in the hands of medical students and junior doctors. Eur Heart J Cardiovasc Imaging (2012) 1.61
Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance. Circulation (2010) 1.60
Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study. J Am Coll Cardiol (2013) 1.58
Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome. Eur Heart J (2006) 1.57
Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study. Circulation (2005) 1.53
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J (2005) 1.52
Recent advances in cardiac resynchronization therapy: echocardiographic modalities, patient selection, optimization, non-responders--all you need to know for more efficient CRT. Int J Cardiovasc Imaging (2009) 1.51
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol (2010) 1.51
The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J Am Coll Cardiol (2008) 1.50
Direct measurement of proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography in mitral regurgitation: a validation study. J Am Soc Echocardiogr (2012) 1.46
Prodromal angina is associated with myocardial salvage in acute ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging (2013) 1.45
Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender. J Cardiovasc Magn Reson (2013) 1.43
Three-dimensional echocardiographic characterization of patients with left ventricular noncompaction. J Am Soc Echocardiogr (2011) 1.41
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 1.33
Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One (2009) 1.32
Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol (2006) 1.28
Left ventricular ejection fraction and volumes: it depends on the imaging method. Echocardiography (2013) 1.28
Assessment of left ventricular function by different speckle-tracking software. Eur J Echocardiogr (2010) 1.23
EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr (2011) 1.21
The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res (2007) 1.20
Predictors of response to cardiac resynchronization therapy (PROSPECT)--study design. Am Heart J (2005) 1.19
Ethnic differences in vascular stiffness and relations to hypertensive target organ damage. J Hypertens (2004) 1.18
Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med (2010) 1.15
European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography. Eur J Echocardiogr (2009) 1.14
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling. Eur Heart J (2011) 1.14
The clinical applications of contrast echocardiography. Eur J Echocardiogr (2007) 1.14
Atrial septal endocarditis. Eur J Echocardiogr (2006) 1.11
The current state of myocardial contrast echocardiography: what can we read between the lines? Eur Heart J Cardiovasc Imaging (2013) 1.11
Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking. Int J Cardiovasc Imaging (2007) 1.10
Erythropoietin in heart and vessels: focus on transcription and signalling pathways. J Thromb Thrombolysis (2008) 1.07
Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. J Allergy Clin Immunol (2009) 1.06
Acute mitral stenosis after transcatheter aortic valve implantation. J Am Coll Cardiol (2012) 1.06
Improved semiautomated quantification of left ventricular volumes and ejection fraction using 3-dimensional echocardiography with a full matrix-array transducer: comparison with magnetic resonance imaging. J Am Soc Echocardiogr (2005) 1.06
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J Immunol (2002) 1.06
Echocardiographic assessment of pulmonary hypertension: standard operating procedure. Eur Respir Rev (2012) 1.06
Registration of multiview real-time 3-D echocardiographic sequences. IEEE Trans Med Imaging (2007) 1.05
Three-dimensional-wall motion tracking: a new and faster tool for myocardial strain assessment: comparison with two-dimensional-wall motion tracking. J Am Soc Echocardiogr (2009) 1.05
Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol (2005) 1.04
Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3. J Immunol (2007) 1.01
EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur J Echocardiogr (2011) 1.01
Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol (2005) 1.00
Assessment of right ventricular structure and function in pulmonary hypertension. J Cardiovasc Ultrasound (2011) 0.99
Stimulated Acoustic Emission Nonbackscatter Contrast Effect of Microbubbles Seen with Harmonic Power Doppler Imaging. Echocardiography (1997) 0.99
Frozen elephant trunk as an effective alternative to open and hybrid two-stage procedures for complex aortic disease. Hellenic J Cardiol (2011) 0.98
The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 0.97
Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens (2005) 0.97
Early myocardial deformation changes associated to isolated obesity: a study based on 3D-wall motion tracking analysis. Obesity (Silver Spring) (2011) 0.96
Real-time three dimensional echocardiography: current and future clinical applications. Heart (2009) 0.96
Multiview fusion 3-D echocardiography: improving the information and quality of real-time 3-D echocardiography. Ultrasound Med Biol (2011) 0.96
Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur J Echocardiogr (2009) 0.95
Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure. Eur Heart J (2007) 0.94
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone. J Neurol (2005) 0.93